Patents by Inventor Michael John Millan

Michael John Millan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline complexes of fluticasone-2-furoate
    Patent number: 7592329
    Abstract: There is provided a crystalline complex comprising a compound of formula (I) in which the crystal lattice is stabilized by the presence of a guest molecule, characterized in that the crystalline complex is of space group P212121 having unit cell dimensions of about 12.5±1.0 §, 15±1.0 §, and 16.2±1.0 § when determined at either 120K or 150K.
    Type: Grant
    Filed: February 4, 2003
    Date of Patent: September 22, 2009
    Assignee: Glaxo Group Limited
    Inventors: Keith Biggadike, Steven John Coote, Andrew Craig, David Malcolm Crowe, Victor Witold Jacewicz, Michael John Millan, Rosalyn Kay Nice, Brian Noga, John Frederick Seager, Andrew Lewis Theophilus
  • Tartrate salt of thiazolidinedione derivative
    Publication number: 20040102485
    Abstract: A novel pharmaceutical compound 5-[4-2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione Meso-Tartrate or a solvate thereof, a process for preparing such a compound, a pharmaceutical composition comprising such a compound and the use of such a compound in medicine.
    Type: Application
    Filed: July 21, 2003
    Publication date: May 27, 2004
    Inventors: Andrew Simon Craig, Tim Chien Ting Ho, Michael John Millan
  • Thiazolidinedione derivative and its use as antidiabetic
    Publication number: 20040044043
    Abstract: A novel pharmaceutical compound 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione ethanesulfonate or a solvate thereof, a process for preparing such a compound, a pharmaceutical composition comprising such a compound and the use of such a compound in medicine.
    Type: Application
    Filed: June 17, 2003
    Publication date: March 4, 2004
    Inventors: Andrew Simon Craig, Michael John Millan
  • 5(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide as pharmaceutical
    Publication number: 20040024027
    Abstract: A novel pharmaceutical compound 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione hydriodide or a solvate thereof, a process for preparing such a compound, a pharmaceutical composition comprising such a compound and the use of such a compound in medicine
    Type: Application
    Filed: June 10, 2003
    Publication date: February 5, 2004
    Inventors: Andrew Simon Craig, Tim Chien Ting Ho, Michael John Millan